glp 1 receptor drugs GLP-1s for Weight Loss: What You Need to Know How GLP-1 medications are transforming

The 20052024 safety record for GLP-1 receptor agonists is extensive, covering millions of patients globally

is supported by operating grants from the CIHR, a Banting and Best Diabetes CentreNovo Nordisk Chair in Incretin Biology and a Sinai HealthNovo Nordisk Foundation Fund in Regulatory Peptides

But their introduction, in addition to the expanding number of indications for which they are used will increase demand, and thereby help drive down cost as more companies enter the market (Mallapaty)

Ophthalmology Sci

doi: 10.1016/j.numecd.2015.04.001 5 IyengarNMGucalpADannenbergAJHudisCA

doi: 10.1016/j.molmet.2018.09.009 [DOI] [PMC free article] [PubMed] [Google Scholar] 20.Min T, Bain SC